
Zimbabwe's HIV Shot Sparks Debate Amid Regional Prevention Efforts
Zimbabwe is set to be among the first countries to roll out lenacapavir, a groundbreaking twice-yearly HIV prophylactic, which has shown over 99% efficacy in trials and is hailed as a potential 'miracle drug' in HIV prevention, though concerns about cost and accessibility remain.
